Principal Investigator: Henry Halperin, M.D., M.A.
Study Coordinator: Rozann Hansford, R.N., M.P.H.
Study Coordinator
Contact Phone: 410-614-6013
Study Coordinator Email: rhansfo2@jhmi.edu
Study Short Title: MRI in Patients Undergoing Cardiac Ablation for Ventricular Tachycardia
Study Long Title: Cardiac Magnetic Resonance Imaging in the Setting of Implantable Cardioverter Defibrillators to Assess Substrate for Ventricular Tachycardia
IRB#: 05-07-22-02
Funding Source: National Heart Lung and Blood Institute/ The Donald W. Reynolds Foundation
Summary of Trial:
Patients with implanted cardiac defibrillators who are scheduled to have a cardiac ablation for ventricular tachycardia undergo an MRI of the heart “pre” procedure to identify scar and to help guide the ablation. Some patients also undergo MRI post procedure and 8 weeks post procedure to help determine whether or not the ablation was successful.
Inclusions: Patients with and ICD; history of ventricular tachycardia and poor heart function in whom myocardial scar is presumed to be identifiable on MRI.
Exclusions:
Patients whose ICD’s are not safe to undergo MRI.
Patients with poor renal function (GFR<30 mL/min) who are not candidates for Gadolinium.
Clinical Trial Site:
Johns Hopkins Hospital
Blalock 5
600 N.Wolfe Street
Baltimore, Md. 21205
Compensation:
$150.00 for the post procedure MRI only (the pre-procedure MRI is considered standard of care for patients undergoing VT ablation).
Start Date: 8-30-05
Anticipated End Date: 8-30-10






